Cornely, OA; Bohme, A; Buchheidt, D et al.
Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology.Haematologica. Bd. 94. H. 1. 2009 S. 113-22
Schetelig, J; Thiede, C; Kiani, A et al.
Prior Treatment with Alemtuzumab Interferes with T-Cell Engraftment After Allogeneic Stem Cell Transplantation in Patients with Chronic Lymphocytic LeukemiaBLOOD. Bd. 114. H. 22. 2009 S. 1301-1301
Becker, C; Taube, C; Bopp, T et al.
Protection from graft-versus-host disease by HIV-1 envelope protein gp120-mediated activation of human CD4(+)CD25(+) regulatory T cellsBLOOD. Bd. 114. H. 6. 2009 S. 1263-1269
Cordonnier, C; Labopin, M; Chesnel, V et al.
Randomized study of early versus late immunization with pneumococcal conjugate vaccine after allogeneic stem cell transplantation.Clin Infect Dis. Bd. 48. H. 10. 2009 S. 1392-401
Thaler, S; Hahnel, PS; Schad, A et al.
RASSF1A Mediates p21(Cip1/Waf1)-Dependent Cell Cycle Arrest and Senescence through Modulation of the Raf-MEK-ERK Pathway and Inhibition of AktCANCER RESEARCH. Bd. 69. H. 5. 2009 S. 1748-1757
Thaler, S; Hahnel, PS; Schad, A et al.
RASSF1A mediates p21Cip1-dependent cell cycle arrest and senescence through modulation of the Raf-MEK-ERK pathway and inhibition of Akt1EUROPEAN JOURNAL OF CELL BIOLOGY. Bd. 88. 2009 S. 10-10
Bellinghausen, I; Luxemburger, U; Tuereci, O et al.
Recruitment of regulatory T cells by CCL18 which is induced in human CD4+T cells from allergic donors after stimulation with IL-10-treated dendritic cellsALLERGY. Bd. 64. 2009 S. 44-45
Stelljes, M; David, M; Arnold, R et al.
Relevance of the Hematopoietic Cell Transplantation-Specific Comorbidity Index (HCT-CI) On Non-Relapse Related Mortality (NRM) in Patients with Acute Lymphoblastic Leukemia (ALL) Receiving Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in First Complete Remission: Results From the GMALL Study GroupBLOOD. Bd. 114. H. 22. 2009 S. 1301-1301
Welters, MJ; van Montfoort, N; Khan, S et al.
Report on the sixth annual meeting of the Association for Immunotherapy of Cancer (CIMT), May 15 and 16, 2008 in Mainz, Germany.Cancer Immunol Immunother. Bd. 58. H. 5. 2009 S. 777-87
Hattenbach, LO; Arndt, CF; Lerche, R et al.
RETINAL VEIN OCCLUSION AND LOW-DOSE FIBRINOLYTIC THERAPY (ROLF) A Prospective, Randomized, Controlled Multicenter Study of Low-Dose Recombinant Tissue Plasminogen Activator Versus Hemodilution in Retinal Vein OcclusionRETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES. Bd. 29. H. 7. 2009 S. 932-940